(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.21% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Dentsply Sirona's revenue in 2026 is $3,681,000,000.On average, 19 Wall Street analysts forecast XRAY's revenue for 2026 to be $731,392,719,633, with the lowest XRAY revenue forecast at $696,135,223,425, and the highest XRAY revenue forecast at $757,234,861,740. On average, 19 Wall Street analysts forecast XRAY's revenue for 2027 to be $747,018,200,907, with the lowest XRAY revenue forecast at $705,951,230,892, and the highest XRAY revenue forecast at $778,669,816,821.
In 2028, XRAY is forecast to generate $765,047,602,377 in revenue, with the lowest revenue forecast at $720,174,425,385 and the highest revenue forecast at $807,516,859,173.